Company Filing History:
Years Active: 2014
Title: Frank Schwobel: Innovator in Nucleic Acid Technology
Introduction
Frank Schwobel is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of nucleic acid technology, holding two patents that showcase his innovative spirit and expertise.
Latest Patents
Schwobel's latest patents include "Lipid Binding Nucleic Acids," which relates to a nucleic acid molecule capable of binding to lipids. Another important patent is "Hepcidin Binding Nucleic Acids," which focuses on a nucleic acid capable of binding to hepcidin. These inventions highlight his commitment to advancing scientific knowledge and applications in biotechnology.
Career Highlights
Frank Schwobel is currently associated with Noxxon Pharma AG, a company dedicated to developing innovative therapies. His work at Noxxon Pharma AG emphasizes his role in the intersection of research and practical applications in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Sven Klussmann and Klaus Buchner. Their collaboration reflects a strong team dynamic that fosters innovation and progress in their respective fields.
Conclusion
Frank Schwobel's contributions to nucleic acid technology and his work at Noxxon Pharma AG underscore his importance as an inventor. His patents not only advance scientific understanding but also pave the way for future innovations in biotechnology.